Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 9/20 | 0.49 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5763481 | 0.98 | TSHR (0.49) | TSHRNPC1POLBMAOBSLC22A6 | |
| SCHEMBL11668249 | 0.88 | MAOB (0.57) | TSHRNPC1POLBMAOBHTT | |
| SCHEMBL13134182 | 0.85 | MAOB (0.45) | NPC1POLBMAOBMAOAKDM4E | |
| SCHEMBL5164924 | 0.84 | MAOB (0.54) | TSHRNPC1POLBMAOBMAOA | |
| SCHEMBL28071452 | 0.81 | MAOB (0.46) | TSHRNPC1POLBMAOBHTT | |
| SCHEMBL4474110 | 0.79 | MAOB (0.47) | TSHRNPC1POLBMAOBMAOA | |
| SCHEMBL31722071 | 0.79 | MAOB (0.46) | NPC1MAOBMAOAMAPTSMN1; SMN2 | |
| SCHEMBL4784331 | 0.79 | MAOB (0.46) | NPC1MAOBMAOAMAPTSMN1; SMN2 | |
| SCHEMBL7443073 | 0.79 | MAOB (0.46) | NPC1MAOBMAOAMAPTSMN1; SMN2 | |
| SCHEMBL12099914 | 0.78 | MAPT (0.51) | TSHRNPC1POLBMAOBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303312-B1 | PROCESS FOR PREPARING (E)-(5,6-DIHYDRO-1,4,2-DIOXAZINE-3-YL)(2-HYDROXYPHENYL)METHANONE O-METHYL OXIME | ARYSTA LIFESCIENCE CORP (JP) | 2023-07-19 | — | — | EP | disclosed |
| EP-3303312-B1 | PROCESS FOR PREPARING (E)-(5,6-DIHYDRO-1,4,2-DIOXAZINE-3-YL)(2-HYDROXYPHENYL)METHANONE O-METHYL OXIME | ARYSTA LIFESCIENCE CORP (JP) | 2023-07-19 | — | — | EP | disclosed |
| EP-3699178-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | Arysta LifeScience Corporation (JP) | 2020-08-26 | — | — | EP | disclosed |
| EP-3699178-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | Arysta LifeScience Corporation (JP) | 2020-08-26 | — | — | EP | disclosed |
| EP-3019495-B1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORP (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-3019495-B1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORP (JP) | 2020-06-03 | — | — | EP | disclosed |
| US-10087152-B2 | Process for preparing (E)-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyl oxime | ARYSTA LIFESCIENCE CORPORATION (JP) | 2018-10-02 | — | — | US | disclosed |
| US-20180148423-A1 | Process for Preparing (E)-(5,6-Dihydro-1,4,2-Dioxazine-3-YL) (2-Hydroxyphenyl) Methanone O-Methyl Oxime | ARYSTA LIFESCIENCE CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| US-20180148423-A1 | Process for Preparing (E)-(5,6-Dihydro-1,4,2-Dioxazine-3-YL) (2-Hydroxyphenyl) Methanone O-Methyl Oxime | ARYSTA LIFESCIENCE CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| US-20180148423-A1 | Process for Preparing (E)-(5,6-Dihydro-1,4,2-Dioxazine-3-YL) (2-Hydroxyphenyl) Methanone O-Methyl Oxime | ARYSTA LIFESCIENCE CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| EP-1417168-A2 | METHOD FOR PRODUCING 2-(HYDROXYPHENYL)-2-(ALKOXYIMINO)-N-METHYLACETAMIDE DERIVATIVES | Bayer CropScience AG (DE) | 2004-05-12 | — | — | EP | disclosed |
| US-6603025-B1 | Used as intermediates for preparing fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 2003-08-05 | — | — | US | disclosed |
| WO-2003055478-A1 | GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-07-10 | — | — | WO | disclosed |
| EP-1232151-B1 | METHOD FOR PRODUCTION OF BENZOFURANONE OXIMES | BAYER CROPSCIENCE AG (DE) | 2003-07-09 | — | — | EP | disclosed |
| WO-2003014066-A2 | METHOD FOR PRODUCING 2-(HYDROXYPHENYL)-2-(ALKOXYIMINO)-N-METHYLACETAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2003-02-20 | — | — | WO | disclosed |
| EP-1232151-A1 | METHOD FOR PRODUCTION OF BENZOFURANONE OXIMES | Bayer Aktiengesellschaft (DE) | 2002-08-21 | — | — | EP | disclosed |
| WO-2001036405-A1 | METHOD FOR PRODUCTION OF BENZOFURANONE OXIMES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-25 | — | — | WO | disclosed |
| US-6057357-A | USEFUL IN TREATING PAIN, INFLAMMATION, PSORIASIS AND IRRITABLE BOWEL SYNDROME | WARNER-LAMBERT COMPANY (US) | 2000-05-02 | — | — | US | disclosed |
| WO-1998049158-A1 | PERIPHERALLY SELECTIVE KAPPA OPIOID AGONISTS | WARNER-LAMBERT COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| CN-1061152-A | ESTER INHIBITORS | CORTECH INC (US) | 1992-05-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10087152-B2 | Process for preparing (E)-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyl oxime | HMOX2, HAO2, HMOX1 | TSHR 3439/4885NPC1 4598/4885POLB 447/4885 |
| US-20180148423-A1 | Process for Preparing (E)-(5,6-Dihydro-1,4,2-Dioxazine-3-YL) (2-Hydroxyphenyl) Methanone O-Methyl Oxime | HMOX2, HAO2, HMOX1 | TSHR 3409/4885NPC1 4586/4885POLB 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.